跳至主要内容
临床试验/IRCT138710101525N1
IRCT138710101525N1已完成3 期

Incidence of clinical sign and symptom of acute ischemia and vascular complication with Enoxaparin during stenting in comparison with heparin

Vice-chanceller for Research Affairs, Shiraz University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with atherosclerotic coronary artery disease (chronic stable angina or acute coronary syndromes) were included if they were candidate for PCI as a result of uncontrolled anginal pain, unresponsive to the maximum dose of nitrates or incidence of adverse drug reactions in which it was impossible to continue medical treatment, Patients with clinical sign of heart failure and ischemic involvement of a relatively large segment of myocardium
  • Exclusion criteria: Age 75 years or older, presence of renal failure defined as creatinine clearance of 30 ml/min and over,creatinine=2.5 mg/dl in male and creatinine=2.0 mg/dl in female participants, use of bare-metal stents, presence of primary PCI, receiving heparin or LMWH before randomization, unacceptable prothrombin time (PT) or platelet count, presence of platelet functional disorders or coagulopathies, or hypercoagulopathy syndromes.

排除标准

  • 未提供

研究者

发起方
Vice-chanceller for Research Affairs, Shiraz University of Medical Sciences

相似试验